Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
folic acid
Arpimed LLC
B03BB01
folic acid
5mg
tablets
(48/2x24/)blisters; (50/5x10) blisters
Prescription
Registered
2017-12-25
SUMMARY PRODUCT CHARACTERISTIC (SPC) FOLIC ACID 5 MG TABLETS 1.1 BRAND NAME – FOLIC ACID 1.2 INTERNATIONAL NON-PROPERTY NAME - FOLIC ACID 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet_ _of _Folic acid, 5 mg _contains: _ACTIVE INGREDIENT: _folic acid – 5 mg; _For a full list of excipients, see section 6.1. _ 3. PHARMACEUTICAL FORM Tablets. Yellow scored on one side and beveled on both sides cylindrical tablets with a few small darker spots, the end surface of which are flat. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Folic acid is indicated for the treatment of megaloblastic anaemia due to folic acid deficiency. It is also used for prophylaxis in chronic haemolytic states, in renal dialysis, and in drug induced folate deficiency. Folic acid is used for the prevention of recurrence of neural tube defects. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults_ IN FOLATE DEFICIENT MEGALOBLASTIC ANAEMIA: 5mg daily for 4 months Up to 15mg daily may be necessary for malabsorption states FOR PROPHYLAXIS IN CHRONIC HAEMOLYTIC STATES OR IN RENAL DIALYSIS: 5mg every 1-7 days depending on diet and underlying disease. IN DRUG INDUCED FOLATE DEFICIENCY: 5mg daily PREVENTION OF RECURRENCE OF NEURAL TUBE DEFECTS 5mg daily starting before conception and continuing throughout the first trimester of pregnancy is recommended. _Children_ Over 1 year : As adult dose Up to 1 year: 500µg/kg daily For dosage and administration of children with various weights it should use Folic acid 1 mg tablets too. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Patients with malignant disease, unless megaloblastic anaemia due to folic acid deficiency. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Folic acid should not be administered for treatment of pernicious anaemia or undiagnosed megaloblastic anaemia without sufficient amounts of cyanocobalamin (vitamin B 12 ) as folic acid alone will not prevent and may precipitate development of subacute combined degeneration Read the complete document